Literature DB >> 18499294

Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.

Arik Dahan1, Amnon Hoffman.   

Abstract

As a consequence of modern drug discovery techniques, there has been a consistent increase in the number of new pharmacologically active lipophilic compounds that are poorly water soluble. A great challenge facing the pharmaceutical scientist is making these molecules into orally administered medications with sufficient bioavailability. One of the most popular approaches to improve the oral bioavailability of these molecules is the utilization of a lipid based drug delivery system. Unfortunately, current development strategies in the area of lipid based delivery systems are mostly empirical. Hence, there is a need for a simplified in vitro method to guide the selection of a suitable lipidic vehicle composition and to rationalize the delivery system design. To address this need, a dynamic in vitro lipolysis model, which provides a very good simulation of the in vivo lipid digestion process, has been developed over the past few years. This model has been extensively used for in vitro assessment of different lipid based delivery systems, leading to enhanced understanding of the suitability of different lipids and surfactants as a delivery system for a given poorly water soluble drug candidate. A key goal in the development of the dynamic in vitro lipolysis model has been correlating the in vitro data of various drug-lipidic delivery system combinations to the resultant in vivo drug profile. In this paper, we discuss and review the need for this model, its underlying theory, practice and limitations, and the available data accumulated in the literature. Overall, the dynamic in vitro lipolysis model seems to provide highly useful initial guidelines in the development process of oral lipid based drug delivery systems for poorly water soluble drugs, and it predicts phenomena that occur in the pre-enterocyte stages of the intestinal absorption cascade.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499294     DOI: 10.1016/j.jconrel.2008.03.021

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  35 in total

1.  Spontaneous emulsification of nifedipine-loaded self-nanoemulsifying drug delivery system.

Authors:  Yotsanan Weerapol; Sontaya Limmatvapirat; Mont Kumpugdee-Vollrath; Pornsak Sriamornsak
Journal:  AAPS PharmSciTech       Date:  2014-10-31       Impact factor: 3.246

Review 2.  The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.

Authors:  Arik Dahan; Jonathan M Miller
Journal:  AAPS J       Date:  2012-03-06       Impact factor: 4.009

3.  In vitro intestinal bioaccessibility of alkylglycerols versus triacylglycerols as vehicles of butyric acid.

Authors:  Diana Martín; María I Morán-Valero; Francisco J Señoráns; Guillermo Reglero; Carlos F Torres
Journal:  Lipids       Date:  2011-01-12       Impact factor: 1.880

4.  Augmented bioavailability of felodipine through an α-linolenic acid-based microemulsion.

Authors:  Mahendra Singh; Jovita Kanoujia; Poonam Parashar; Malti Arya; Chandra B Tripathi; V R Sinha; Shailendra K Saraf; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

5.  Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines.

Authors:  Atheer Zgair; Jonathan Cm Wong; Jong Bong Lee; Jatin Mistry; Olena Sivak; Kishor M Wasan; Ivo M Hennig; David A Barrett; Cris S Constantinescu; Peter M Fischer; Pavel Gershkovich
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

6.  Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.

Authors:  Matthew J Jackson; Umesh S Kestur; Munir A Hussain; Lynne S Taylor
Journal:  Pharm Res       Date:  2016-02-18       Impact factor: 4.200

7.  The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.

Authors:  Arik Dahan; Avital Beig; Viktoriya Ioffe-Dahan; Riad Agbaria; Jonathan M Miller
Journal:  AAPS J       Date:  2012-12-15       Impact factor: 4.009

8.  Effect of ingested lipids on drug dissolution and release with concurrent digestion: a modeling approach.

Authors:  Fulden Buyukozturk; Selena Di Maio; David E Budil; Rebecca L Carrier
Journal:  Pharm Res       Date:  2013-12       Impact factor: 4.200

9.  In vitro lipolysis and intestinal transport of β-arteether-loaded lipid-based drug delivery systems.

Authors:  Patrick B Memvanga; Pierre Eloy; Eric M Gaigneaux; Véronique Préat
Journal:  Pharm Res       Date:  2013-06-06       Impact factor: 4.200

10.  Optimization of Landscape Phage Fusion Protein-Modified Polymeric PEG-PE Micelles for Improved Breast Cancer Cell Targeting.

Authors:  Tao Wang; Valery A Petrenko; Vladimir P Torchilin
Journal:  J Nanomed Nanotechnol       Date:  2012-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.